Stockhub

Wuhan General Group: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 August 2022

14 August 2022

7 August 2022

  • curprev 13:0713:07, 7 August 2022‎ Paris talk contribs‎ 534 bytes +534‎ Created page with "Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Gro..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Wuhan_General_Group’